You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Pediatrics/Children's Health Trials

Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.

Page 1 of 1 | Results 1 - 7 of 7

A Phase 3 trial of Setmelanotide (RM-493), a Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström syndrome (AS) Patients with Moderate to Severe Obesity

Rushika Conroy, MD
Diabetes, Obesity, Pediatrics

Baystate Children’s Specialty Center, 50 Wason Avenue, Springfield, MA

Recruiting

Community Study of Outcome Monitoring for Emotional Disorders in Teens (COMET)

Peter Thunfors, PhD
Mental Health, Pediatrics

Baystate Medical Center, 759 Chestnut St, Springfield, MA

Recruiting

Improving Outcome in Neonatal Abstinence Syndrome: a study to compare treatment options for infants with Neonatal Abstinence Syndrome (NAS) due to narcotic exposure in the womb

To compare treatment options for infants with Neonatal Abstinence Syndrome (NAS) due to narcotic exposure in the womb and evaluate the effects of treatment on long-term neurodevelopmental outcome at 18 months of age.

Pediatrics

Baystate Children's Hospital, 759 Chestnut Street, Springfield, MA 01199

Active

Non-invasive Clinical Pectus Index as a Measurement of Severity in Pectus

Michael Tirabassi, MD
Surgery, Pediatrics

Baystate Medical Center, 759 Chestnut St, Springfield, MA

Recruiting

Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES)

Bruce Waslick, MD
Mental Health, Pediatrics

Baystate Medical Center, 759 Chestnut St, Springfield, MA

Active

Study to evaluate efficacy of recombinant human Clara Cell 10 KDA Protein (CC10) administered to premature infants with respiratory distress syndrome

Bronchopulmonary dysplasia (BPD) is a chronic lung disease of premature infants characterized by marked inflammation and alveolar hypoplasia. Presently there are no known medications which prevent the development of BPD. The purpose of the present study is to evaluate the ability of a single intratracheal dose of recombinant human CC10 to prevent the development of long-term respiratory complications and BPD in ventilated premature infants. 

Laura Madore, MD
Pediatrics, Pregnancy

Baystate Medical Center, 759 Chestnut Street, Springfield, MA 01199

The IBT Connection Study

Pregnancy, Pediatrics

Baystate Medical Center, 759 Chestnut St, Springfield, MA

Page 1 of 1 | Results 1 - 7 of 7